Introduction
Invasive mycoses are serious life-threatening infections in immunocompromised patients.
Antifungal drugs that are available for the treatment of these infections include azole derivatives, candin derivatives and amphotericin B. Azole antifungal agents are widely used for the treatment of fungal infections due to their broad-spectrum activities and improved safety profiles. 1 However, there is great concern about the development of azole-resistant isolates of Candida albicans due to their widespread, prolonged use. 2 Candin antifungal agents show potent antifungal activity against Candida and Aspergillus; however, they show no antifungal activity against Cryptococcus neoformans.
3 Amphotericin B exhibits broad-spectrum and fungicidal activity; however, due to the significant side effects that it causes, its clinical utility is limited to controlled intravenous administration. 4 Therefore, it is imperative that new antifungal agents that have potent broad-spectrum activities, novel mechanisms of action and fewer side effects are developed.
T-2307, i.e. 4-{3-[1-(3-{4-[amino(imino)methyl]phenoxy}
propyl)piperidin-4-yl]propoxy}benzamidine, is a novel arylamidine synthesized by Toyama Chemical Co., Ltd. Under both in vitro and in vivo conditions, T-2307 exhibits broad-spectrum activities against the majority of fungal pathogens, including Candida spp., Cryptococcus neoformans and Aspergillus fumigatus. T-2307 exhibits potent in vitro and in vivo activity, particularly against C. albicans. T-2307 belongs to the class of aromatic diamidines that includes pentamidine and furamidine (DB75). Pentamidine is a drug that has been widely used to treat pneumocystosis, leishmaniasis and trypanosomiasis. 6, 7 Pafuramidine (DB289) had been developed as a prodrug of furamidine (DB75), and had been demonstrated to have good efficacy against trypanosomiasis, pneumocystosis and malaria. 8, 9 It is generally accepted that the preferential uptake of these diamidine compounds by parasite-specific transporters contributes to the specific antiparasitic activities by facilitating the intracellular accumulation of these drugs to toxic concentrations. 10 -12 We therefore hypothesized that T-2307 is also transported into C. albicans via a transporter-mediated system. In this report, we studied the uptake of [ 14 C]T-2307 in C. albicans to determine whether C. albicans has a T-2307 transport system. and 2% glucose. The cells were harvested during the log phase of growth by centrifugation at 1700 g for 10 min at room temperature. After washing with saline, the cells were suspended in 10 mM phosphate buffer solution (PB) or 10 mM PB supplemented with 1% glucose (PBG).
Materials and methods

Materials
Isolation of rat hepatocytes
Rats were anaesthetized with an intraperitoneal injection of sodium pentobarbital (50 mg/kg; Dainippon Sumitomo Pharma Co., Ltd, Osaka, Japan) and subjected to celiotomy. The liver was perfused for 5 min with liver perfusion medium (Invitrogen Corporation, Carlsbad, CA, USA) warmed to 398C (at 15 mL/min along with oxygen) and then perfused for 10 -15 min with liver digest medium (Invitrogen Corporation) warmed to 398C (at 20 mL/min along with oxygen). After perfusion, the liver sample was transferred into a cell culture dish filled with 20 mL of ice-cold William's medium E (Sigma-Aldrich). Cellular aggregates and tissue debris were removed, and the hepatocytes were gently suspended using a disposable pipette. The hepatocyte suspension was filtered using a cell strainer on ice and centrifuged at 50 g for 3 min at 48C to collect hepatocytes. The hepatocytes were then washed with 30 mL of hepatocyte wash medium (Invitrogen Corporation) and were gently suspended with 15-20 mL of William's medium E. The hepatocyte suspension was mixed with 10× Hank's buffered salt solution and Percoll (Sigma-Aldrich) (mixture ratio, 10:1:9, v/v/v), and centrifuged at 50 g for 10 min at 48C. The supernatant containing dead cells was removed and the pellet was gently suspended with a small quantity of William's medium E. The cells were then counted to estimate their viability after staining with Trypan Blue. Subsequently, the hepatocyte suspension was diluted with William's medium E supplemented with 5 mM glucose. All animal experimental procedures were conducted in accordance with the guidelines for care and use of laboratory animals at Toyama Chemical Co., Ltd. 14 C]T-2307 in 50 mL of 10 mM PB or 10 mM PBG. Cells were incubated in the presence of various concentrations of unlabelled T-2307 (0.01-100 mM) for kinetic studies and in the presence of various concentrations of unlabelled pentamidine (0.01-100 mM) or several inhibitors if necessary. The concentrations of the inhibitors were set based on previous reports. 13 -15 The uptake of [ 14 C]T-2307 in the presence and absence of sodium orthovanadate was measured in PBG, including 0.1 mM magnesium chloride. 16 Rat hepatocytes were exposed to 0.02 mM [ 14 C]T-2307 in 5 mL of William's medium E supplemented with 5 mM glucose. The cell concentration of C. albicans and rat hepatocytes was 1.0×10 6 cells/mL. After incubation, the cells were concentrated to obtain sufficient counts to measure the [ 14 C]T-2307 accumulated in cells. For C. albicans, 50 mL of 2 mol/L sodium hydroxide, 100 mL of silicon oil/liquid paraffin mixture (2:1 mixture, v/v) and 200 mL of cell suspension (containing 1.0×10 7 cells) were layered in a tube in this order, and centrifuged at 10000 g for 1 min at 48C. For rat hepatocytes, 100 mL of 2 mol/L sodium hydroxide, 150 mL of silicon oil/liquid paraffin mixture (3:1 mixture, v/v) and 200 mL of cell suspension (containing 1.0×10 6 cells) were layered in a tube in this order, and centrifuged at 5590 g for 20 s at room temperature. After centrifugation, a part of the silicon oil/liquid paraffin mixture was cut using a razor to recover the sodium hydroxide layer, which contained C. albicans cells or rat hepatocytes. The lower part of the mixture in the tube was transferred into a glass scintillation vial and allowed to stand for 60 min to solubilize C. albicans cells or rat hepatocytes. Subsequently, 50 mL of 2 mol/L hydrochloride solution was added to neutralize the solution. The radioactivities of the samples were measured in 10 mL of Hionic fluor with a Tri-Carb 2500TR (PerkinElmer, Inc., Waltham, MA, USA) liquid scintillation counter for 30 min. All results were expressed as means+SEM of triplicate experiments and statistical analysis was performed with the parametric Dunnett's multiple comparison test. P values of ,0.05 (two-tailed) were considered to be significant. SAS version 8.2 (SAS Institute Japan Ltd, Tokyo, Japan) was used as the analytical software. Intracellular concentrations were calculated based on the assumption that C. albicans cells and rat hepatocytes are spherical, with diameters of 5 and 20 mm, respectively.
17,18
Kinetic studies of uptake
The apparent kinetic parameters, K m (Michaelis constant) and V max (maximal transport rate), of T-2307 uptake in C. albicans were calculated by non-linear least-squares regression analysis using WinNonlin software (Pharsight, Inc., Mountain View, CA, USA), according to the following Michaelis -Menten-type equations:
(1)
where V and [S] are the velocity of substrate uptake and saturable concentration, respectively. Data were fitted to Equation (2) with two transport components, where the indices 1 and 2 indicate the high-and low-affinity components, respectively. 7 cells after incubation in PB and PBG, respectively. The addition of glucose resulted in a 2-fold increase in the uptake of [ 14 C]T-2307 in C. albicans TIMM 1623, indicating that T-2307 uptake was energy dependent. T-2307 was also highly accumulated in azole-resistant C. albicans ATCC 64550 and ATCC MYA-574 overexpressing the ABC transporter genes CDR1 and CDR2, which encode ATP-dependent efflux pumps, 19 suggesting that T-2307 was not effluxed by these pumps.
Results
The intracellular concentrations in C. albicans TIMM 1623 cells in PB and PBG were 43.7 and 92.1 mM, respectively, which were 2200-to 4600-fold higher than the starting extracellular concentration. The intracellular concentrations in other C. albicans cells were 3200-to 5100-fold higher than the starting extracellular concentration. On the other hand, the intracellular concentration in rat hepatocytes was 0.691 mM after incubation with 0.02 mM (Figure 1b) . The pH dependence data showed decreasing uptake with decreasing pH. The data were not consistent with the idea that the cationic species T-2307 simply equilibrates across the plasma membrane in response to the pH gradient or the idea that proton symport plays a role in T-2307 uptake. These data suggest that the protonation state of key amino acid residues within the T-2307 transporter would affect the uptake.
Effects of various inhibitors on [
14 C]T-2307 uptake in C. albicans
To investigate the nature of the force driving the uptake, the effects of various inhibitors on the uptake of 0.02 mM [ 14 C]T-2307 in C. albicans TIMM 1623 for 5 min were studied (Figure 1c) . Inhibitors of mitochondrial respiration, KCN (10 mM) and sodium azide (5 mM), significantly decreased T-2307 uptake (49.69%+1.35% and 21.52%+0.64% of the control, respectively). 2,4-Dinitrophenol (5 mM), an inhibitor of oxidative phosphorylation, also significantly decreased T-2307 uptake (15.96%+0.56% of the control).
The protonophore CCCP is an uncoupler of oxidative phosphorylation that equilibrates proton concentration across biological membranes. CCCP (250 mM) significantly decreased T-2307 uptake (26.32%+1.83% of the control).
These results indicated that energy was required for the T-2307 uptake across the plasma membrane and that an actively metabolizing mitochondrion played an important role.
Diamidines are known to be accumulated in the mitochondrion within a few minutes, with uptake being driven by the mitochondrial membrane potential of cells. 13, 14 The inhibitors used here could affect the mitochondrial membrane potential, which would affect the accumulation into the mitochondrion and this would then affect the uptake into the cell. These results also indicated that T-2307 would be accumulated in C/E ratio refers to the ratio of the intracellular concentration to the starting extracellular concentration (0.02 mM). c These data were obtained from Mitsuyama et al.
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1683 JAC the actively metabolizing mitochondrion, with uptake being driven by the mitochondrial membrane potential.
Organisms that make use of active transport by proton motive force generally have a DCCD-sensitive proton-extruding ATPase on their plasma membrane, which maintains the transmembrane proton and electrical gradients. 20, 21 DCCD (100 mM) significantly decreased T-2307 uptake (38.55%+3.19% of the control). Sodium orthovanadate (5 mM), a plasma membranetype proton ATPase inhibitor, also significantly reduced T-2307 uptake (60.51%+6.29% of the control). These results suggested that the plasma membrane pH gradient would play a role in T-2307 uptake. However, these results were not consistent with the pH dependence results.
DCCD, a non-specific proton ATPase inhibitor, inhibits not only plasma membrane proton ATPase but also mitochondrial proton ATPase. Vanadate is also known to affect mitochondrial respiration by altering electron transfer between complexes III and IV. 22 In view of the findings and the pH dependence data, these results indicated that T-2307 uptake would be affected by the intracellular pH or mitochondrial metabolism rather than by the plasma membrane pH gradient. 
C]T-2307 uptake in C. albicans in the presence of different quantities of unlabelled T-2307 and pentamidine
To further characterize T-2307 uptake in C. albicans, the uptake of 0.02 mM [ 14 C]T-2307 uptake in C. albicans TIMM 1623 was measured for 5 min in the presence of various concentrations of unlabelled T-2307 (0.01-100 mM). T-2307 uptake was concentration dependent (Figure 2a and b) and an Eadie-Hofstee plot clearly yielded two slopes (Figure 2c and d) . This indicated the involvement of two different transport systems. We obtained the velocity by subtraction of the uptake at 48C as the binding to the cell wall and the non-specific uptake from the uptake at 308C, indicating that neither of the two transport systems represented the binding and the non-specific uptake. Therefore, we fitted the data to a two-transporter model and determined the apparent kinetic parameters for two transport systems. The apparent kinetic parameters were as follows: high-affinity transport system (K m1 ¼0.0234+0.0092 mM, V max1 ¼0.159+0.024 pmol/10 7 cells/s) and low-affinity transport system (K m2 ¼102+26 mM, V max2 ¼50.4+9.5 pmol/10 7 cells/s). We already showed that the uptake of T-2307 at low concentration (0.02 mM) was temperature and pH sensitive, and energy dependent. Furthermore, in the presence of 100 mM unlabelled T-2307, the uptake of 0.02 mM [
14 C]T-2307 was reduced by 94% (Figure 3) , indicating that the majority of T-2307 uptake at low concentration occurs via a saturable, carrier-mediated process, with only minor non-saturable component. These data indicated that the high-affinity transport system could be a carrier-mediated system.
To determine whether the additional low-affinity transport system is also a carrier-mediated system, T-2307 uptake in C. albicans TIMM 1623 at a higher concentration was studied. Nishikawa et al.
(5 mM) significantly decreased the T-2307 uptake in PBG (19.61%+2.48% and 59.23%+5.44% of the control, respectively). After incubation with 100 mM T-2307 for 5 min at 48C in PBG, C. albicans cells accumulated T-2307 up to a concentration of 6.91+0.43 mM. These results suggested that the low-affinity transport system was temperature sensitive and energy dependent.
Because the structure of T-2307 is similar to that of diamidines such as pentamidine, we hypothesized that a common transport system is responsible for the accumulation of these compounds in C. albicans. To test this hypothesis, the uptake of 0.02 mM [
14 C]T-2307 in C. albicans TIMM 1623 was measured in the presence of various concentrations of unlabelled T-2307 and pentamidine (0.01 -100 mM) (Figure 3 ). The uptake of [ 14 C]T-2307 in C. albicans was inhibited by pentamidine only at higher concentrations than unlabelled T-2307. In the presence of 1 mM unlabelled T-2307 and pentamidine, the uptake of 0.02 mM [ 
Discussion
In the present study, we characterized the transport properties of the novel arylamidine antifungal agent T-2307 across the cell membrane of C. albicans. These data indicated that T-2307 was transported into C. albicans via two transport systems.
Based on the determination of apparent K m and V max values for these transport systems, it is predicted that 90% of the T-2307 uptake via the transport systems is mediated via the high-affinity carrier at the MIC against C. albicans (0.001 mg/L, 0.002 mM). We consider that the typical potent anticandidal activity of T-2307 arises due to the high accumulation via the high-affinity carrier. 
Uptake of T-2307 in Candida albicans
Pentamidine is also known to be transported to parasites via several transporter-mediated systems.
In African trypanosomes, pentamidine uptake appears to involve the P2 nucleoside transporter and two additional transporters, a low-capacity high-affinity pentamidine transporter (HAPT1) and a high-capacity low-affinity pentamidine transporter (LAPT1). 23, 24 Loss of the P2 nucleoside transporter can mediate resistance to diamidines. 25, 26 The P2 nucleoside transporter displayed high affinity (K i ¼ 0.43+0.02 mM) for pentamidine. 27 The K m values for pentamidine transport into Trypanosoma brucei via HAPT1 and LAPT1 were 0.036+0.006 and 56.2+8.3 mM, respectively. 24 These K m values were comparable to the apparent K m values for the T-2307 uptake.
In Leishmania spp., pentamidine uptake has been shown to be saturable, involving a carrier-mediated, energy-dependent process. 28, 29 However, a previous study showed that pentamidine did not enter Leishmania parasites via a nucleoside transporter. 13 Pentamidine was found to be an inhibitor of arginine and polyamine transport in Leishmania donovani and Leishmania mexicana. 30 -32 However, experiments using radiolabelled pentamidine in L. mexicana failed to show reciprocal inhibition with arginine and polyamines.
Pentamidine uptake in L. donovani has also been reported to occur via a secondary non-saturable route in addition to the saturable high-affinity transporter.
14 The presence of the second route was indicated by a failure of up to 1 mM cold pentamidine to completely inhibit the uptake of 1 mM [ 3 H]pentamidine. Furthermore, the secondary route could be measured in wild-type cells but not in resistant cells with decreased mitochondrial membrane potential. The authors speculated that fast accumulation of pentamidine into the mitochondrion removed the drug from the cytosol and maintained a concentration gradient across the plasma membrane, allowing continuous uptake in cells; thus, the second non-saturable component could represent uptake into the mitochondrion.
In the kinetic study of T-2307, a 5 min uptake period was required to give significant counts of accumulated [ and this appeared to fall within the linear range (Figure 1a) . Considering that diamidines are accumulated into the mitochondrion within a few minutes, 13, 14 it cannot be ruled out that this time period actually represents not only initial uptake rates across the plasma membrane but also the accumulation into the mitochondrion. The inhibitor study indicated that T-2307 would be accumulated into the mitochondrion within this time period, with uptake being driven by the mitochondrial membrane potential. Furthermore, the inhibitory effect of unlabelled T-2307 to 0.02 mM [ 14 C]T-2307 uptake became weaker at a concentration of .1 mM and even 100 mM unlabelled T-2307 failed to completely inhibit the [ 14 C]T-2307 uptake (Figure 3 ). In view of these results and the report about pentamidine, the low-affinity component indicated by the Eadie -Hofstee plot could represent T-2307 accumulation into the mitochondrion within the time period tested, although the T-2307 uptake study at higher concentration suggested that it could be a low-affinity carrier.
The uptake of [ 14 C]T-2307 in C. albicans was inhibited by pentamidine only at higher concentrations than unlabelled T-2307, suggesting that pentamidine has lower affinity to the T-2307 transport system. On the other hand, it cannot be ruled out that pentamidine inhibits the function required for T-2307 uptake at higher concentrations; although it has been reported that 100 mM pentamidine has almost no inhibitory effect on the respiration of whole yeast cells. 12 Further studies are required to determine the inhibitory behaviour of pentamidine on T-2307 uptake and to identify the T-2307 transporter.
Lanteri et al. 12 reported that Saccharomyces cerevisiae cells grown in a medium containing glycerol, which is the nonfermentative carbon source, were more sensitive to the growth-inhibitory effects of DB75 or pentamidine than cells grown in a medium containing dextrose, suggesting that DB75 and pentamidine inhibit the mitochondrial functions of cells. Similarly, in a study of T-2307, S. cerevisiae cells cultured in a medium containing glycerol were more susceptible to the growth-inhibitory effects of T-2307 than those cultured in a medium containing glucose. 33 Therefore, we now consider that one of the mechanisms of action of T-2307 may be similar to that of DB75 and pentamidine.
In conclusion, the considerably higher concentrations of T-2307 were selectively accumulated in C. albicans via transportermediated systems, as compared with the concentrations in rat hepatocytes. This transporter-mediated uptake of T-2307 in C. albicans contributes to its potent anticandidal activity. Nishikawa et al.
